Multiregional rtfMRI Neurofeedback for the Prevention of Alzheimer's Disease (NPAD)
NCT03173846 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2020-07-21
Summary
This study aims to predict cognitive decline using a performance endophenotype of neuro-feedback based on functional magnetic resonance imaging in real time in a population at risk for Alzheimer's disease (AD).
Conditions
- Alzheimer Disease
Sponsors & Collaborators
-
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
lead OTHER
Eligibility
- Min Age
- 45 Years
- Max Age
- 79 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-05-05
- Primary Completion
- 2018-10-31
- Completion
- 2019-12-31
Countries
- Spain
Study Locations
More Related Trials
-
Neurofeedback as a Treatment Tool for Depression
NCT01544205 ·Status: COMPLETED ·Phase: NA
-
Antibody-mediated NMDA Receptor Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Prolonged Recovery Stage
NCT06183788 ·Status: RECRUITING ·Phase: NA
-
Neurofeedback to Treat Depression
NCT05169346 ·Status: COMPLETED ·Phase: NA
-
Effect of Amygdala Neurofeedback on Depressive Symptoms and Processing Biases
NCT02079610 ·Status: COMPLETED ·Phase: NA
-
Comparing Real-time fMRI Neurofeedback Versus Sham for Altering Limbic and Eating Disturbances in Anorexia Nervosa
NCT04220112 ·Status: COMPLETED ·Phase: NA
-
Targeting Large-scale Networks in Depression With Real-time Functional Magnetic Resonance Imaging (fMRI) Neurofeedback
NCT06050070 ·Status: RECRUITING ·Phase: NA
-
Individual Differences in Cognitive Control Predict Real-time fMRI Neurofeedback Performance
NCT07211269 ·Status: RECRUITING ·Phase: NA
-
Real-time fMRI Neurofeedback for Mild/Moderate Depression
NCT05025904 ·Status: COMPLETED ·Phase: NA
-
Neuropsychological and Brain Medical Imaging Study in Patients With Brain Damage
NCT01849549 ·Status: COMPLETED ·Phase: NA
-
Neurofeedback in Clinical High Risk
NCT06492343 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Neurofeedback to Treat Depression - 2
NCT07159061 ·Status: RECRUITING ·Phase: NA
-
Imaging of New Learning in Severe Alzheimer's Disease Patients
NCT01839422 ·Status: UNKNOWN ·Phase: NA
-
Neurofeedback in Patients With Frontal Brain Lesions
NCT02957695 ·Status: COMPLETED ·Phase: NA
-
Compensatory Brain Mechanisms for Amygdala-associated Cognitive Dysfunction: Potential Role of the Cortical Mirror Neuron System
NCT03723733 ·Status: UNKNOWN
-
Study Pilot - Hybrid EEG/fMRI Neurofeedback in Depressed Patients
NCT04450186 ·Status: UNKNOWN ·Phase: NA
-
Modification in Cortical Activation in Pseudophakic Patients With Visual Difficulties After a Multifocal Implantation
NCT02529098 ·Status: WITHDRAWN ·Phase: NA
-
Descriptive Pilot Study of the Effects of a Standardized Neuromodulation Program on Cortical Brain Function in Chronic Low Back Pain Patients
NCT03929952 ·Status: COMPLETED ·Phase: NA
-
Symptom Based Treatment Affects Brain Plasticity - Cognitive Training in Patients With Affective Symptoms
NCT03183947 ·Status: COMPLETED ·Phase: NA
-
Development of MRI Protocols and Associated Explorations (EEG, NIRS) in Healthy Volunteers
NCT03152539 ·Status: COMPLETED ·Phase: NA
-
Neurofeedback for Treatment-resistant Obsessive-compulsive Disorder (OCD)
NCT03956771 ·Status: UNKNOWN ·Phase: NA
-
Tinnitus Related Cerebral Activities
NCT02853812 ·Status: TERMINATED ·Phase: NA
-
Network Neurofeedback Using 7-Tesla MRI to Reduce Rumination Levels in Depression
NCT05933148 ·Status: RECRUITING ·Phase: NA
-
Functional Magnetic Resonance Imaging - Synthetic Aperture Magnetometry (fMRI-SAM) and Alzheimer's Disease
NCT00412048 ·Status: WITHDRAWN ·Phase: NA
-
Development of a New Neuroimaging Method Aimed to Differentiate Mnesic Abilities of Alzheimer and Depressed Patients
NCT02840045 ·Status: UNKNOWN ·Phase: NA
-
FMRI-neurofeedback in Depression
NCT05640089 ·Status: RECRUITING ·Phase: NA